X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (25) 25
gastroenterology & hepatology (22) 22
humans (21) 21
male (19) 19
female (16) 16
middle aged (16) 16
aged (15) 15
hepatocellular carcinoma (12) 12
adult (11) 11
care and treatment (11) 11
hepatoma (11) 11
interferon (11) 11
analysis (10) 10
liver (10) 10
gastroenterology (9) 9
hepatitis c (9) 9
hepatology (9) 9
abdominal surgery (8) 8
aged, 80 and over (8) 8
colorectal surgery (8) 8
hepatitis c virus (8) 8
medicine & public health (8) 8
ribavirin (8) 8
surgical oncology (8) 8
treatment outcome (8) 8
hepatitis (7) 7
multivariate analysis (7) 7
patient outcomes (7) 7
prognosis (7) 7
survival (7) 7
young adult (7) 7
chemotherapy (6) 6
patients (6) 6
retrospective studies (6) 6
risk factors (6) 6
sorafenib (6) 6
antimitotic agents (5) 5
antineoplastic agents (5) 5
biological response modifiers (5) 5
cancer (5) 5
cardiac & cardiovascular systems (5) 5
cirrhosis (5) 5
daclatasvir (5) 5
diagnosis (5) 5
hcv (5) 5
health aspects (5) 5
hepatitis b (5) 5
hepatocellular-carcinoma (5) 5
infection (5) 5
intraarterial 5-fluorouracil (5) 5
liver cancer (5) 5
recurrence (5) 5
therapy (5) 5
virology (5) 5
antiviral agents - therapeutic use (4) 4
asunaprevir (4) 4
encephalopathy (4) 4
hepatic arterial infusion chemotherapy (4) 4
hepatitis c, chronic - drug therapy (4) 4
interferon-alpha (4) 4
liver cirrhosis (4) 4
medical research (4) 4
medicine, experimental (4) 4
peripheral vascular disease (4) 4
prevalence (4) 4
risk-factors (4) 4
virus (4) 4
adolescent (3) 3
age factors (3) 3
antiviral agents (3) 3
carcinoma, hepatocellular - diagnosis (3) 3
carcinoma, hepatocellular - virology (3) 3
child (3) 3
chronic hepatitis c (3) 3
combination therapy (3) 3
drug therapy (3) 3
drug therapy, combination (3) 3
efficacy (3) 3
genetic aspects (3) 3
genetic-variation (3) 3
genome-wide association (3) 3
hepatic artery (3) 3
infusions, intra-arterial (3) 3
interferon-alpha - therapeutic use (3) 3
japanese patients (3) 3
kaplan-meier estimate (3) 3
liver diseases (3) 3
liver neoplasms - diagnosis (3) 3
liver neoplasms - virology (3) 3
metastasis (3) 3
percutaneous coronary intervention (3) 3
predictor (3) 3
ribavirin - therapeutic use (3) 3
risk (3) 3
survival rate (3) 3
sustained virological response (3) 3
telaprevir (3) 3
thrombosis (3) 3
vein tumor thrombosis (3) 3
viruses (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Gastroenterology, ISSN 0944-1174, 1/2018, Volume 53, Issue 1, pp. 107 - 118
Biomarkers predicting the response to the anticancer treatment and prognosis in patients with advanced hepatocellular carcinoma (HCC) are required. Recently,... 
High mobility group box 1 | Liver cancer | Biomarker | Medicine & Public Health | Colorectal Surgery | Hepatic arterial infusion chemotherapy | Hepatology | Sorafenib | Gastroenterology | Abdominal Surgery | HCC | Surgical Oncology | VEIN TUMOR THROMBOSIS | APOPTOSIS | PROTEIN-KINASE-C | 5-FLUOROURACIL/INTERFERON COMBINATION THERAPY | GROUP BOX 1 | INTERFERON-ALPHA | PATHWAY | JAPANESE PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | INTRAARTERIAL 5-FLUOROURACIL | PROGRESSION | Multivariate Analysis | Sorafenib - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Hepatic Artery | Male | Survival Rate | Antineoplastic Agents - administration & dosage | Disease Progression | Liver Neoplasms - blood | Young Adult | Carcinoma, Hepatocellular - pathology | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Liver Neoplasms - pathology | Aged | Carcinoma, Hepatocellular - blood | HMGB1 Protein - blood | Infusions, Intra-Arterial | Antimitotic agents | Medical research | Chemotherapy | Chromosomal proteins | Liver diseases | Analysis | Liver | Medicine, Experimental | Hepatoma | Antineoplastic agents | Cancer | Tumor markers | Hepatic vein | Medical prognosis | Hepatocellular carcinoma | Multivariate analysis | HMGB1 protein | Survival | Index Medicus
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 3/2017, Volume 52, Issue 3, pp. 366 - 375
Journal Article
Journal of gastroenterology, ISSN 0944-1174, 09/2019, pp. 1 - 10
This study investigated time-course changes in skeletal muscle volume per year with tolvaptan in patients with refractory ascites that was unresponsive to loop... 
Edema | Prognosis | Medical imaging | Liver | Antagonists | Multivariate analysis | Aldosterone | Survival | Skeletal muscle | Furosemide | Cirrhosis | Sarcopenia | Musculoskeletal system | Computed tomography | Medical prognosis | Diuretics | Ascites | Index Medicus
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 05/2010, Volume 298, Issue 5, pp. 1320 - 1329
Although mesenchymal stem cells (MSCs) have therapeutic potential for tissue injury, intolerance and poor cell viability limit their reparative capability.... 
Myocardial ischemia | Cell transplantation | Heme oxygenase-1 | Apoptosis | Mesenchymal stem cells | PROGENITOR CELLS | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | REPERFUSION INJURY | HEART-FAILURE | apoptosis | INFARCTED MYOCARDIUM | heme oxygenase-1 | IMPROVES CARDIAC-FUNCTION | TRANSPLANTATION | cell transplantation | CARBON-MONOXIDE | mesenchymal stem cells | ENDOTHELIAL-CELLS | IN-VIVO | PERIPHERAL VASCULAR DISEASE | myocardial ischemia | Capillaries - pathology | Oxidative Stress - physiology | Rats, Inbred Lew | Culture Media, Serum-Free | Male | Vascular Endothelial Growth Factor A - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | RNA - isolation & purification | Bone Marrow Transplantation | Ultrasonography | Myocardial Ischemia - diagnostic imaging | Cell Differentiation | Heme Oxygenase-1 - biosynthesis | Cytokines - metabolism | Cell Survival | Rats | Reverse Transcriptase Polymerase Chain Reaction | Myocardial Ischemia - pathology | Cell Lineage | RNA - biosynthesis | Phenotype | Animals | Myocardial Ischemia - therapy | Apoptosis - physiology | Mesenchymal Stem Cell Transplantation | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Transplantation | Research | Vascular endothelial growth factor | Stem cells | Proteins | Ischemia | Bone marrow | Physiology | Gene expression | Index Medicus
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 12/2014, Volume 49, Issue 12, pp. 1548 - 1556
Older patients with chronic hepatitis C have a lower virological response to interferon (IFN) treatment compared to younger patients. The efficacy of... 
Medicine & Public Health | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Older patients | Telaprevir | Hepatitis C virus | IFNL4 | Surgical Oncology | RVR | PLUS RIBAVIRIN | VIRUS | COMBINATION THERAPY | ITPA POLYMORPHISM | GENETIC-VARIATION | HEPATOCELLULAR-CARCINOMA | CORE REGION | PEGYLATED INTERFERON | VIRAL RESPONSE | GASTROENTEROLOGY & HEPATOLOGY | GENOME-WIDE ASSOCIATION | Recombinant Proteins - therapeutic use | Multivariate Analysis | Predictive Value of Tests | Age Factors | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Dose-Response Relationship, Drug | Young Adult | Interleukins - genetics | Ribavirin - administration & dosage | Adult | Female | Drug Therapy, Combination | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Interferon-alpha - administration & dosage | Regression Analysis | Aged | Oligopeptides - administration & dosage | Polymorphism, Single Nucleotide | Care and treatment | Patient outcomes | Analysis | Physiological aspects | Hemoglobin | Aged patients | Genetic aspects | Interferon | Biological response modifiers | Hepatitis C | Ribavirin | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2017, Volume 12, Issue 8, pp. e0182710 - e0182710
The risk of hepatocellular carcinoma (HCC) development is reduced following viral elimination by interferon therapy in chronic hepatitis C patients. However,... 
SUSTAINED VIROLOGICAL RESPONSE | HEPATITIS-C VIRUS | CIRRHOSIS | MULTIDISCIPLINARY SCIENCES | LIVER FIBROSIS | PHASE-3 TRIAL | INFECTION | RECURRENCE | DACLATASVIR | JAPANESE PATIENTS | GENOME-WIDE ASSOCIATION | Interferon-alpha - pharmacology | Carcinoma, Hepatocellular - epidemiology | Carcinoma, Hepatocellular - prevention & control | Humans | Middle Aged | Hepatitis C, Chronic - complications | Viral Load | Incidence | Young Adult | Liver Neoplasms - epidemiology | Isoquinolines - pharmacology | Aged, 80 and over | Adult | Imidazoles - therapeutic use | Drug Therapy, Combination | Liver Neoplasms - prevention & control | Liver Neoplasms - virology | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Risk Factors | Interferon-alpha - therapeutic use | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Carcinoma, Hepatocellular - virology | Imidazoles - pharmacology | Hepatitis C, Chronic - drug therapy | Sulfonamides - pharmacology | Sulfonamides - therapeutic use | Isoquinolines - therapeutic use | Aged | Ribavirin - pharmacology | Antiviral agents | Control | Care and treatment | Causes of | Dosage and administration | Research | Hepatoma | Comparative analysis | Hepatitis C virus | Health aspects | Ribavirin | Risk factors | Therapy | Laboratories | Research & development--R&D | Hepatocellular carcinoma | Risk | Infections | Genomes | Metabolism | Patients | Hepatitis | Liver cancer | Polyethylene glycol | Hepatology | Gastroenterology | Life sciences | Interferon | Hepatitis C | Index Medicus | Research & development | R&D
Journal Article
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 12/2018, Volume 90, Issue 12, pp. 1834 - 1840
Journal Article
Circulation, ISSN 0009-7322, 07/2015, Volume 132, Issue 4, pp. 241 - 250
Journal Article